Wegovy (semaglutide injection): This once-weekly injectable is the hallmark of GLP-1 weight loss medications, reducing body weight by an average of 14.9% in trials
Discontinuation, regain, and reinitiation (class-level, semaglutide / tirzepatide) Budini 2026 ( eClinicalMedicine ) pooled regain curve: asymptotic maximum regain 75.3% of lost weight, half-life about 23 weeks, so roughly 60% of the loss returns by 12 months and about 40% is still held at a year
Discussion Based on metagenomic sequencing, our study found that the diversity and composition of gut microbiota were significantly altered in the PCOS group, resulting in disrupted microbiota functions
The surface of the lesions is slightly bumpy and, on palpation, is often velvety or very slightly rough
The goal is not to achieve a number on a scale and stop it is to rebuild a metabolic baseline that makes the results sustainable